Tsuneo Imai Selected Research

Proteinuria

1/2022

Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsuneo Imai Research Topics

Disease

20	Neoplasms (Cancer) 03/2024 - 06/2002
16	Breast Neoplasms (Breast Cancer) 12/2017 - 06/2002
9	Thyroid Neoplasms (Thyroid Cancer) 04/2024 - 04/2003
5	Neoplasm Metastasis (Metastasis) 05/2023 - 06/2002
5	Papillary Thyroid Cancer 01/2022 - 08/2003
5	Pheochromocytoma 12/2019 - 01/2006
4	Hyperplasia 01/2015 - 04/2003
3	Paraganglioma (Paragangliomas) 12/2019 - 11/2012
3	Adenoma (Adenomas) 01/2013 - 04/2003
3	Cushing Syndrome 11/2012 - 04/2003
2	Lymphatic Metastasis 07/2011 - 01/2011
2	Acth-Independent Macronodular Adrenal Hyperplasia 01/2011 - 04/2003
2	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2009 - 05/2003
2	Hyperparathyroidism 01/2009 - 03/2002
2	Adrenal incidentaloma 01/2006 - 04/2003
1	Thrombocytopenia (Thrombopenia) 05/2023
1	Anemia 05/2023
1	Hypothyroidism 12/2022
1	Tracheal Stenosis 01/2022
1	Disease Progression 01/2022
1	Proteinuria 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2016
1	Febrile Neutropenia 03/2016
1	Circulating Neoplastic Cells 01/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 05/2013
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 05/2013
1	Primary Hyperparathyroidism 01/2013
1	Adrenocortical Carcinoma 11/2012
1	Insulinoma 01/2012
1	Anaplastic Thyroid Carcinoma 06/2010
1	Hyperthermia 02/2009
1	Lymphadenopathy 11/2007

Drug/Important Bio-Agent (IBA)

3	IodineIBA 04/2024 - 07/2016
3	lenvatinibIBA 04/2024 - 11/2018
3	human ERBB2 proteinIBA 01/2024 - 01/2004
3	Docetaxel (Taxotere)FDA Link 10/2010 - 01/2004
3	Messenger RNA (mRNA)IBA 01/2009 - 06/2002
3	Proteins (Proteins, Gene)FDA Link 01/2006 - 05/2003
2	Sorafenib (BAY 43-9006)FDA Link 09/2023 - 01/2022
2	Progesterone Receptors (Progesterone Receptor)IBA 05/2023 - 12/2017
2	Estrogen ReceptorsIBA 05/2023 - 12/2017
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2016
2	alpha-Methyltyrosine (Metirosine)FDA Link 12/2019 - 03/2018
2	CatecholaminesIBA 12/2019 - 03/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 10/2010
2	Chromogranin AIBA 01/2015 - 09/2010
2	Peptides (Polypeptides)IBA 01/2015 - 01/2011
2	SynaptophysinIBA 01/2015 - 09/2010
2	Codon (Codons)IBA 05/2013 - 05/2003
2	Toremifene (Fareston)FDA Link 01/2012 - 01/2011
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011 - 04/2003
2	Trastuzumab (Herceptin)FDA Link 10/2010 - 01/2004
1	Capsules (Microcapsules)IBA 03/2024
1	Hormones (Hormone)IBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 05/2023
1	Thyroid HormonesIBA 12/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2019
1	Epidermal Growth Factor (EGF)IBA 12/2017
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 03/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016
1	UridineIBA 03/2016
1	Glutathione S-Transferase piIBA 03/2016
1	Epirubicin (Ellence)FDA LinkGeneric 03/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	AntigensIBA 01/2016
1	Proglucagon (Glucagon Precursors)IBA 01/2015
1	Glucagon (Glukagon)FDA Link 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2013
1	Thyroglobulin FDA Link 01/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2013
1	AldosteroneIBA 11/2012
1	MetanephrineIBA 11/2012
1	Mitotane (Lysodren)FDA Link 11/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2012
1	Aromatase InhibitorsIBA 01/2012
1	gastric inhibitory polypeptide receptorIBA 01/2011
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	Oxidoreductases (Dehydrogenase)IBA 01/2011
1	Tamoxifen FDA LinkGeneric 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Phosphopyruvate Hydratase (Enolase)IBA 09/2010
1	Ferrosoferric Oxide (Magnetite)FDA Link 02/2009

Therapy/Procedure

8	Therapeutics 07/2016 - 01/2004
5	Drug Therapy (Chemotherapy) 05/2016 - 01/2004
4	Radiotherapy 01/2022 - 12/2009
4	Thyroidectomy 01/2019 - 08/2003
3	Adrenalectomy 11/2012 - 04/2003
3	Parathyroidectomy 01/2009 - 03/2002
2	Lymph Node Excision (Lymph Node Dissection) 07/2011 - 01/2011
2	Autologous Transplantation 01/2009 - 03/2002
2	Neck Dissection (Radical Neck Dissection) 01/2009 - 11/2007
1	Sternotomy 01/2011